Decline of olfactory function in Parkinson's disease: A ten-year longitudinal study
- PMID: 40383932
- DOI: 10.1177/1877718X241298708
Decline of olfactory function in Parkinson's disease: A ten-year longitudinal study
Erratum in
-
Erratum to "Decline of olfactory function in Parkinson's disease: A ten-year longitudinal study".J Parkinsons Dis. 2025 May;15(3):673. doi: 10.1177/1877718X251333920. Epub 2025 Apr 2. J Parkinsons Dis. 2025. PMID: 40176528 No abstract available.
Abstract
BackgroundOlfactory dysfunction is a prodromal sign of Parkinson's disease (PD) present in up to 90% of patients. However, it is unclear whether or not olfactory function worsens over the course of the disease.ObjectiveIn this study we examined whether the rate of decline of olfactory function in PD patients exceeds the expected age-related decline.MethodsOlfactory function was tested in 90 PD patients at baseline (age at baseline 58.3 years, 68.9% males) and an average 10 years later using the 40-item University of Pennsylvania Smell Identification Test (UPSIT). To screen for concomitant cognitive deficits as a potential confounder, the Mini-Mental State Examination (MMSE) was used.ResultsAt baseline, the mean UPSIT score was 22 points. Over the average 10-year follow-up period olfactory function decreased in 81.1% of PD patients, even in the youngest patients in whom no age-related decline was expected. The mean decrease was six UPSIT points (p < 0.001), which exceeds the expected age-related decline derived from a previous study. When excluding patients with an MMSE score below 24, reflecting cognitive deficits that might interfere with olfactory test performance, UPSIT score still decreased by almost 7 points over the follow-up period.ConclusionsOlfactory function in PD declines more rapidly with increasing disease duration than can be explained by aging or cognitive decline alone. As such, olfactory function appears to be a clinical marker of disease progression in PD that can be measured non-invasively and deserves consideration as part of multimodal phenotyping to monitor disease progression.
Keywords: Parkinson disease; cognition; disease progression; smell.
Plain language summary
Up to nine out of ten patients with Parkinson's disease (PD) experience olfactory loss. We wanted to find out if this loss further declines with disease progression. We tested the sense of smell in 90 PD patients at the start of study and again about ten years later using the University of Pennsylvania Smell Identification Test (UPSIT). Patients were around 58 years old at study entry and most were men. We also tested their cognitive functioning to make sure it did not affect the smell test results. We found that the sense of smell got worse in eight out of ten PD patients over the ten years of follow-up. Also this was found in younger patients who wouldn’t normally lose that much of their sense of smell due to aging. On average, the smell test scores dropped by six points (out of a total of 40 points), which is more than expected in normal aging. Even after excluding patients with cognitive problems, the drop in UPSIT score was still about seven points. This shows that the sense of smell worsens faster in people with PD than would be expected from aging or cognitive decline alone. Therefore, testing olfactory function could be a useful way to monitor the progression of PD in a non-invasive way.
Conflict of interest statement
Declaration of conflicting interestsRL Doty is President of, and major shareholder in, Sensonics International, the manufacturer and distributor of smell and taste tests, including the test employed in this study.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials